Khaitan & Co, alongside Simpson Thacher & Bartlett LLP, is advising Amneal Pharmaceuticals on its proposed USD 1.075 billion acquisition of Kashiv Biosciences LLC. The transaction includes the company’s two Indian subsidiaries, Kashiv Biosciences Private Limited and Kashiv Research Private Limited.
